| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $41.95B | $41.03B | $39.29B |
| YoY Revenue Growth % | +2.2% | +4.4% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $4.51B | $4.37B | $2.54B |
| Operating Margin % | 10.8% | 10.6% | 6.5% |
| Net Income (GAAP) | $4.18B | $4.17B | $2.06B |
| EBITDA (Normalized) | $5.67B | $5.78B | $3.95B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $4.76B | $4.39B | $3.88B |
| Capital Expenditures (CapEx) | $1.45B | $1.77B | $1.77B |
| Free Cash Flow (FCF) | $3.31B | $2.62B | $2.11B |
| FCF Margin % | 7.9% | 6.4% | 5.4% |
| Return on Invested Capital (ROIC %) | 13.0% | 13.5% | 7.0% |
| Cash & Short-Term Equivalents | $4.40B | $4.35B | — |
| Total Debt (Short + Long Term) | $15.16B | $14.69B | $11.03B |
| Total Stockholders' Equity | $16.67B | $15.29B | $22.63B |